Modalis Therapeutics (TYO:4883) issued 21,900 new shares as part of post-delivery restricted-stock-based remuneration, according to a Wednesday filing on the Tokyo Stock Exchange.
The shares were priced at 77 yen each, raising a total of 1.7 million yen.
The allotment included 6,600 shares to three directors, two of whom are outside directors, and 4,200 shares to four employees, including former staff.
Another 11,100 shares were granted to seven current and former employees of subsidiaries.
Price (JPY): $79.00, Change: $+2.0, Percent Change: +2.60%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.